These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein. Ho DH; Seol W; Son I Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480 [TBL] [Abstract][Full Text] [Related]
26. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase. Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383 [TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease. Henderson MX; Sengupta M; Trojanowski JQ; Lee VMY Acta Neuropathol Commun; 2019 Nov; 7(1):183. PubMed ID: 31733655 [TBL] [Abstract][Full Text] [Related]
29. LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons. Henderson MX; Changolkar L; Trojanowski JQ; Lee VMY J Parkinsons Dis; 2021; 11(3):1187-1196. PubMed ID: 33720852 [TBL] [Abstract][Full Text] [Related]
30. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093 [TBL] [Abstract][Full Text] [Related]
31. Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology. Mamais A; Manzoni C; Nazish I; Arber C; Sonustun B; Wray S; Warner TT; Cookson MR; Lewis PA; Bandopadhyay R Brain Res; 2018 Dec; 1701():75-84. PubMed ID: 30055128 [TBL] [Abstract][Full Text] [Related]
32. A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2. Dusonchet J; Kochubey O; Stafa K; Young SM; Zufferey R; Moore DJ; Schneider BL; Aebischer P J Neurosci; 2011 Jan; 31(3):907-12. PubMed ID: 21248115 [TBL] [Abstract][Full Text] [Related]
33. TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT. Ling H; Kara E; Bandopadhyay R; Hardy J; Holton J; Xiromerisiou G; Lees A; Houlden H; Revesz T Neurobiol Aging; 2013 Dec; 34(12):2889.e5-9. PubMed ID: 23664753 [TBL] [Abstract][Full Text] [Related]